Applying this method, during the study period 126 patients were diagnosed with congenital steroid metabolism defects, including 106 patients with 21-hydroxylase deficiency, 5 patients with 11β-hydroxylase deficiency, one patient with 3β-hydroxysteroid dehydrogenase type II deficiency and 14 patients with 5α-reductase type 2 deficiency.